Listen To The Latest Episode of The Recruitment and Beyond Podcast

Hear from Hayley Raeper, People Lead at xDesign, on maintaining your company culture as you grow.  

Cytochroma

Cytochroma

Preclinical testing faster, safer and smarter

Work for Cytochroma
Eden Scott
Eden Scott
Eden Scott
Eden Scott

Predict Clinical Success

Cytochroma manufacture genetically diverse stem cell-derived models to predict the safety and effect of drugs in a global population.

Our stem cell library contains unique genetic backgrounds the FDA has highlighted as lacking in clinical trials.

Cytochroma’s automated cell manufacture, physiologically relevant models and rapid screening platform makes our preclinical testing faster, safer and smarter.

Cytochroma
Eden Scott
Eden Scott
Eden Scott
Eden Scott

IPS Library

Cytochroma is growing the world’s most diverse induced pluripotent stem cell (iPSC) library so that new drugs can be tested in distinct genetic backgrounds ahead of clinical trials.

Their ethically sourced cells are expanded under fully defined conditions, each line displays wide genetic diversity and unique cytochrome P450 polymorphisms. Offering unparalleled insight into how compounds will be metabolised in a global population.

These powerful models can help you:

  • Understand Differential Metabolism

  • Enable Better Prediction of Safety

  • Shape Future Clinical Trials

Cytochroma
Eden Scott
Eden Scott
Eden Scott
Eden Scott

Liver Models

To enable the rapid and reproducible implementation of cellular disease models in vitro, Cytochroma provides differentiated iPS-derived models from a diverse bank of iPS cell lines.

Cytochroma offers flexible and bespoke iPS-derived cell models through their standard catalogue and custom cell manufacturing.

Cytochroma
The Cytochroma Team

Based in Roslin, Cytochroma is a small but dynamic team. Founder and CEO Dr Kate Cameron is an award-winning entrepreneur. A graduate of Edinburgh University, Kate is an experienced stem cell scientist who has attracted the support of an incredibly knowledgeable board.

Kate is supported by Scientific Manager Kora Przybyszewska, who secured her PhD from Queens University Belfast and has been with the company for over two years now.

In The News

Cytochroma has recently secured £1m funding to take the company to the next level. Take a look at some recent media coverage about the raise.